Galapagos NV ADR (GLPG)

NASDAQ
Currency in USD
28.99
+0.09(+0.31%)
Closed·
After Hours
28.990.00(0.00%)
·
GLPG Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
GLPG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
28.8229.48
52 wk Range
22.3631.23
Key Statistics
Edit
Prev. Close
28.9
Open
29.23
Day's Range
28.82-29.48
52 wk Range
22.36-31.23
Volume
533.92K
Average Vol. (3m)
352.34K
1-Year Change
-0.96%
Book Value / Share
45.11
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GLPG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
28.17
Downside
-2.83%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Galapagos NV ADR Company Profile

Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.

Compare GLPG to Peers and Sector

Metrics to compare
GLPG
Peers
Sector
Relationship
P/E Ratio
−9.5x−3.3x−0.5x
PEG Ratio
0.060.030.00
Price / Book
0.6x2.2x2.6x
Price / LTM Sales
5.9x4.3x3.0x
Upside (Analyst Target)
−14.0%99.6%48.7%
Fair Value Upside
Unlock8.9%9.2%Unlock

Analyst Ratings

0 Buy
4 Hold
2 Sell
Ratings:
6 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 28.17
(-2.83% Downside)

Earnings

Latest Release
Apr 23, 2025
EPS / Forecast
-2.67 / -0.0991
Revenue / Forecast
85.28M / 70.02M
EPS Revisions
Last 90 days

People Also Watch

104.30
CRUS
-1.54%
30.700
TGS
-2.26%
15.340
HMY
-0.32%
78.94
TER
-3.04%
200.67
GRMN
-1.52%

FAQ

What Is the Galapagos ADR (GLPG) Stock Price Today?

The Galapagos ADR stock price today is 28.99

What Stock Exchange Does Galapagos ADR Trade On?

Galapagos ADR is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Galapagos ADR?

The stock symbol for Galapagos ADR is "GLPG."

What Is the Galapagos ADR Market Cap?

As of today, Galapagos ADR market cap is 1.94B.

What Is Galapagos ADR's Earnings Per Share (TTM)?

The Galapagos ADR EPS (TTM) is -2.72.

When Is the Next Galapagos ADR Earnings Date?

Galapagos ADR will release its next earnings report on Jul 23, 2025.

From a Technical Analysis Perspective, Is GLPG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Galapagos ADR Stock Split?

Galapagos ADR has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.